Stan Vashovsky Net Worth: How to Estimate It Accurately

Stan Vashovsky (full name Stanley Vashovsky) is the co-founder and former CEO of DocGo and Ambulnz, and publicly available estimates of his net worth range from roughly $170,000 to $28 million depending on which data source you use and what assumptions it makes. That gap is not a typo. It reflects a real methodological problem: some tools count only the shares he currently holds on disclosed SEC filings, while others factor in historical equity grants, prior exits, and broader career earnings. If you are comparing these estimates specifically to the chai vasarhelyi net worth style of reporting, the key is to verify the methodology and the date behind each number. The most evidence-backed approach places his liquid and disclosed wealth considerably below the higher estimates, especially after a notable stake reduction in early 2026, but his full financial picture almost certainly includes assets that never appear in any public filing.

Who Stan Vashovsky is (and how to confirm you have the right person)

Stanley Vashovsky is a New York City-based entrepreneur whose career in healthcare and technology spans more than three decades. He founded Medcare in 1992, an early healthcare venture that Philips Healthcare acquired in 2001, after which Vashovsky joined Philips as Vice President of Innovations. He later co-founded Ambulnz, a technology-enabled medical transportation company, which became the foundation for DocGo. DocGo went public via a SPAC merger with Motion Acquisition Corp, and Vashovsky served as CEO and chairman of the board for eight years before stepping down as CEO and transitioning to non-executive Chairman, as documented in DocGo's 2023 proxy statement filed with the SEC.

The name variant matters here. His official biography uses "Stanley Vashovsky," but SEC filings, DocGo investor relations materials, and press releases consistently use the shortened form "Stan Vashovsky." They refer to the same individual. If you are researching this name, that is your identity confirmation: co-founder of DocGo (ticker: DCGO), former CEO, former chairman, and current consulting advisor under a formal agreement with the company. A Schedule 13D filed under his name in SEC EDGAR, plus a Form 424B3 registration document listing him as a named selling securityholder, give you the clearest documentary proof of identity and equity ownership.

There is no widely documented second public figure named Stan or Stanley Vashovsky who would create meaningful identity ambiguity in a financial research context. Still, as with any search on a reference site like this one, it is worth cross-referencing the DocGo EDGAR filing history and his official biography URL before accepting any net worth number. If a source does not tie the name to DocGo, Ambulnz, or Medcare, treat it skeptically.

What "net worth" actually means here

Net worth is total assets minus total liabilities. For a private individual like Vashovsky (who is connected to a public company but is not himself a publicly reporting entity), you cannot simply look up a balance sheet. Instead, you build a model from the pieces you can observe: publicly disclosed equity holdings, known compensation figures, documented business exits, and reported consulting income. What you cannot observe directly are private investments, real estate holdings, personal debt, tax obligations, and any proceeds from prior liquidity events that were never disclosed separately.

When a tool like MarketScreener reports a net worth of $170,392 as of April 29, 2026, it is almost certainly using a narrow definition: the market value of his currently disclosed DCGO share holdings at that date's stock price. That is a floor, not a ceiling. When Benzinga reports $28 million as of May 21, 2026, it is likely using a broader dataset that incorporates historical equity grants, vesting schedules, prior sales, and possibly external estimates of non-disclosed assets. Neither number is wrong exactly, they are just answering different questions. The transparent approach is to acknowledge both, explain what each one measures, and build a range rather than cite a single figure.

The best verified sources to find his financial data

For Stan Vashovsky, the richest primary sources are all publicly available and free to access. Here is where to go, in order of reliability:

1. SEC EDGAR (edgar.sec.gov): Search for "Stanley Vashovsky" or "Stan Vashovsky" as a filer. You will find his Schedule 13D and 13D/A beneficial ownership filings, DocGo's proxy statements (DEF 14A), Form 10-Q and 10-K filings referencing his consulting agreement, and Form 424B3 registration filings listing his share counts. These are the gold standard for verifying identity and equity-linked wealth.
2. DocGo Investor Relations (dcgo.com/investors): Links to all SEC filings, including annual reports and ownership-change forms. The 2023 proxy documents his CEO transition and equity compensation structure. The 10-Q filed for the period ending September 30, 2024 details the Vashovsky Consulting Agreement signed March 7, 2024.
3. StockTitan or similar SEC filing mirrors: The Schedule 13D/A reposted here confirmed that as of February 24, 2026, Vashovsky's beneficial ownership had dropped to 241,348 shares representing 0.2% of outstanding DCGO stock, meaning he is no longer a greater-than-5% beneficial owner.
4. StockAnalysis or similar market cap trackers: DocGo's market cap was approximately $432.69 million at December 31, 2024, and had fallen to roughly $65 million by May 29, 2026. This collapse in share price directly erodes any net worth estimate tied to DCGO equity.
5. Benzinga and GuruFocus insider profiles: Useful secondary sources for cross-referencing estimated net worth and insider trading activity, but they derive figures from the same SEC data, often with different assumptions baked in. Use them to check your range, not as standalone answers.
6. His official biography (stanleyvashovsky.com or equivalent): Provides the career timeline and milestone anchors (Medcare founding 1992, Philips acquisition 2001, Ambulnz/DocGo co-founding) that support a wealth-building narrative.

How he built his wealth: a timeline

Understanding where the money came from matters as much as the current number. Vashovsky's wealth-building arc has three distinct phases.

Phase 1: Medcare and the Philips exit (1992 to 2001)

Vashovsky founded Medcare in 1992, positioning it at the intersection of healthcare services and technology at a time when that combination was still unusual. Philips Healthcare's acquisition in 2001 was the first major liquidity event in his career. The exact transaction value is not publicly documented in detail, but any founder-level exit to a major healthcare corporation would represent a meaningful capital event. Following the acquisition, he stayed on as VP of Innovations at Philips, giving him both liquidity and continued industry expertise.

Phase 2: Ambulnz and the DocGo SPAC merger

Co-founding Ambulnz introduced a technology layer to medical transportation, a sector that had seen relatively little disruption. The company rebranded and evolved into DocGo, which went public through a SPAC merger with Motion Acquisition Corp. Vashovsky served as CEO and chairman for eight years. A public listing typically creates significant paper wealth for founding executives through equity stakes, though the actual realized value depends on share price at vesting dates and any sales executed. DocGo's equity grant dates for Vashovsky are documented: May 12, 2023; November 10, 2023; December 12, 2023; and March 15, 2024. These grants were valued using the FASB ASC Topic 718 grant-date fair value method, a standard SEC-defined approach that records compensation at the time of issuance rather than at vesting.

Phase 3: Post-CEO advisory role (2024 onwards)

After stepping down as CEO, Vashovsky entered a formal Vashovsky Consulting Agreement with DocGo, signed March 7, 2024. The agreement structures his advisory compensation as quarterly equity grants with a stated grant date fair value of approximately $35,000 per quarter. That is roughly $140,000 per year in equity-based advisory income at grant-date valuations, before accounting for share price movements. The 10-K filed February 27, 2025 notes that no accounts payable or accrued liabilities were tied to this agreement as of certain reporting dates, confirming the arrangement is equity-only rather than cash-based.

Breaking down assets and liabilities: building the range

Because Vashovsky is a private individual connected to a public company, the honest approach is to build a range with a floor (publicly verifiable), a mid-range (reasonable assumptions), and a ceiling (broad estimates including non-disclosed assets).

Working through this structure, a defensible floor for Vashovsky's disclosed-equity-only net worth sits around $170,000 as of mid-2026, reflecting the steep decline in DocGo's share price from a $432M market cap at end of 2024 to roughly $65M by late May 2026. A mid-range estimate that incorporates prior equity realizations, the Philips exit, and some conservative assumptions about private assets could reasonably land somewhere between $5 million and $15 million. Benzinga's $28 million figure for May 2026 represents the higher end of plausible estimates, likely layering in historical equity peaks and broader asset assumptions.

Current net worth snapshot and why it keeps changing

As of June 2026, the most honest single-sentence answer is: Stan Vashovsky's verifiable disclosed net worth from public equity holdings is approximately $170,000, while broader estimates accounting for undisclosed wealth and prior earnings likely place his total net worth somewhere in the $5 million to $28 million range. The uncertainty is not evasion; it reflects real data gaps. If you are comparing this kind of uncertainty to other creators, reviews of Cyrus Veyssi net worth typically explain how they separate public holdings from unverifiable estimates.

The biggest driver of change right now is DocGo's share price. The company's market cap dropped from $432.69 million at the end of 2024 to about $65 million by late May 2026, a loss of more than 85% in roughly 17 months. For anyone whose wealth is concentrated in DCGO equity, that move is devastating. Vashovsky's February 2026 Schedule 13D/A filing confirms he reduced his stake to 0. To estimate Vashovsky's net worth responsibly, always combine disclosed filings with the share-price and methodology that each site uses. 2%, meaning he either sold most of his shares (potentially locking in gains at higher prices earlier) or transferred them. If he sold at 2024 valuations, the proceeds could be substantial. If those sales happened near the 2026 lows, the picture is different. The filing alone cannot tell you the price at which shares were sold.

This kind of volatility is common among founders of publicly traded companies, and it is why profiles of similarly positioned entrepreneurs (such as those covered elsewhere on this site) often carry wide ranges rather than precise figures. The wealth number is real but it moves with the market.

How to verify these numbers and handle the uncertainty

If you want to do your own check on Stan Vashovsky's net worth, here is the practical workflow that gives you the most evidence-based result in the least time.

1. Confirm identity first: Go to SEC EDGAR and search "Stanley Vashovsky." Verify you see Schedule 13D and 13D/A filings related to DocGo (ticker DCGO). Cross-reference with DocGo's investor relations page to confirm the same individual is named in proxy statements and executive certifications.
2. Pull the most recent beneficial ownership filing: The 13D/A from around February 2026 establishes his current stake at 241,348 shares (0.2%). Multiply that by DCGO's current share price to get your disclosed equity floor.
3. Check the current share price: Look up DCGO on any financial data site. At a market cap of roughly $65M and approximately 117 million shares outstanding as of mid-2026, a 0.2% stake would be valued at around $130,000 to $170,000.
4. Factor in equity grant history: Review the Form 10-Q (period ending September 30, 2024) and the DEF 14A for grant dates and approximate values. These give you the income side of the equity timeline.
5. Apply the range honestly: Treat $170,000 as your disclosed floor, use $5M–$15M as a reasonable middle estimate incorporating prior exits and equity realizations, and flag Benzinga's $28M as the high-end estimate with broader (less verifiable) assumptions.
6. Check for updates regularly: Beneficial ownership filings, consulting agreement amendments, and any new equity grant disclosures can shift the picture. Set a reminder to re-pull the EDGAR filings quarterly.

One thing to watch for: when a secondary site like Benzinga or GuruFocus reports a net worth figure, it is always worth asking what date the data reflects and what methodology was used. MarketScreener's $170,392 figure dated April 29, 2026 is actually more precise because it is explicitly tied to a single observable input (disclosed share value). Benzinga's $28 million is a higher-level estimate that probably factors in more context, but with less transparency about its inputs. Neither is definitively correct; they are measuring different things.

For anyone researching wealth profiles in this space, Vashovsky's case is a useful illustration of why a single number rarely tells the full story. The same dynamic applies to other entrepreneurs profiled here whose wealth is tied to a single public company or a mixture of historical exits and current equity holdings. The methodology matters as much as the figure itself, and the most credible estimates are always the ones that show their work.